The Joshua Frase Foundation for Congenital Myopathy Research Inc

Analysis

The Joshua Frase Foundation for Congenital Myopathy Research Inc is a registered charity in United States, based in Ponte Vedra, FL. It received its IRS tax-exemption ruling in July 1997, 29 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2022, The Joshua Frase Foundation for Congenital Myopathy Research Inc reported income of $67k and spending of $90k, spending 134% of what it took in. Across the 4 years on record, from December 2019 to December 2022, income fell from $85k to $67k (-21%), an average of -7.6% a year. The sharpest change came in the year to December 2021, when income rose by 218%. Over the whole period it spent 127% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, The Joshua Frase Foundation for Congenital Myopathy Research Inc sits at the 20th percentile: it is larger than about 20% of them. Against every charity in United States with reported income it ranks in the 26th percentile, and in the 30th percentile within FL. Charities of a similar size with the same main cause include Mora Crisis Pregnancy Center Inc ($67k), Brooke Army Medical Center Womens Auxiliary ($67k) and Rochelle Community Hospital Foundation ($67k).

On its Form 990 for the period ending December 2022, revenue came from contributions and grants 100% of the total. Compensation of current officers, directors and key employees was $55k (62% of expenses). At year end it held assets of $75k against liabilities of $8,969, net assets of $66k. It reported 1 employees.